Doctor profile · Federal record
Dr. Ananda Walaliyadda, M.D.
Specialist (CMS: Rheumatology) · Pocatello, ID
- NPI 1497747703
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1448 E Center St, Suite E
Pocatello, ID 832014132
(208) 234-1300
fax (208) 234-1333
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- June 29, 2022
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Idaho #M8731
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1497747703. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
399,621
Distinct HCPCS
10
Medicare allowed
$4,884,430
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 191,744 | 66 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 92,133 | 140 | $13 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 56,400 | 21 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 34,304 | 64 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 12,194 | 51 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 5,280 | 58 | $23 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,629 | 169 | $1 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 1,154 | 281 | $58 | |
96372 |
Injection of drug or substance under skin or into muscle | 595 | 220 | $13 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 518 | 129 | $118 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 12,109. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$133
Transactions
6
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 2 | $50.31 | |
| UCB, Inc. | 1 | $34.68 | |
| Celgene Corporation | 1 | $25.22 | |
| GlaxoSmithKline, LLC. | 1 | $16.61 | |
| Organon Llc | 1 | $6.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,223
Patients
782
Total drug cost
$1,118,693
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 293 | 222 | $2,550 |
| Hydroxychloroquine Sulfate | Generic | 201 | 114 | $24,929 |
| Methotrexate (Methotrexate Sodium) | Brand | 201 | 145 | $7,411 |
| Leflunomide | Generic | 68 | 48 | $6,915 |
| Humira(Cf) Pen (Adalimumab) | Brand | 67 | 24 | $475,115 |
| Allopurinol | Generic | 64 | 40 | $1,109 |
| Celecoxib | Generic | 63 | 45 | $6,534 |
| Enbrel Sureclick (Etanercept) | Brand | 52 | 14 | $378,617 |
| Sulfasalazine | Generic | 40 | 31 | $1,253 |
| Leucovorin Calcium | Generic | 36 | 23 | $2,003 |
Hospital affiliations
Frequently asked questions
What is Dr. Ananda Walaliyadda's medical specialty?
Dr. Ananda Walaliyadda practices Specialist in Pocatello, ID.
Where does Dr. Ananda Walaliyadda practice?
Dr. Ananda Walaliyadda practices at 1448 E Center St, Pocatello, ID 832014132. Office phone: 2082341300.
What is Dr. Ananda Walaliyadda's NPI?
Dr. Ananda Walaliyadda's National Provider Identifier (NPI) is 1497747703, issued by NPPES.
Does Dr. Ananda Walaliyadda accept Medicare assignment?
Yes. Dr. Ananda Walaliyadda accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ananda Walaliyadda commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717). Source: CMS Medicare Physician & Other Practitioners file.